Remdesivir An Indian Scientist's Invention

"Remdesivir" Is Developed By Gilead Science, A Pharmaceutical Based In Foster City, California. 

The Drug Was Developed By "RAMESH E.M. DESIGAN" Team Led By Czech Scientist Tomas Cihlar, Primarily For Treatment Of Ebola Virus.

Not Many Know Of The Story Behind The Development and Naming Of this Drug. 

It Is Actually Named After "Ramesh E.M. Desigan", The Lead Scientist In The Team Of Tomas Cihlar.

"Ramesh" Hails From Rasipuram, Near Salem In Tamil Nadu. Coming From A Poor Family, Ramesh Received A Scholarship To Study At Madras Christian College, Followed By A Ph.D. In Pharmacology From "JNU" New Delhi.

In 2002 "Ramesh" Moved To California, To Work For Gilead Sciences & Was Instrumental In Identifying the Viral Pathway, That Could Be Blocked By Anti-viral Drugs.

Initially Called Ebpantuvir, The Name Was Changed In Honor Of The Inventor Of The Drug To "REMDesiVir". from the extracts of his name. 

Additionally, In Honor Of This Discovery, Gilead Donated $2 Million To The Rasi International School Where he did his primary education. But very few Indians know about this interesting story -cascade and share this with your friends and relatives

 

Information collected from reliable internet sources. 

Sudesh DJV writes on contemporary subjects in the form of Articles and poems which is in the interest of the Nation in particular and for Mankind in general.